ALSA-BIO3: Building future success through biomarkers
Speaker: Shafeeq S. Ladha, M.D., Barrow Neurological Institute
ALSA-BIO3 is an observational clinical study funded by ALSA and the Fulton Family Foundation. In this study, biofluids as well as clinical and electrophysiologic measures will be collected from the same participants at multiple time points, and placed in repositories for future use. By building the NEALS Biobank, BIO3 helps to bolster a resource that will help scientists and clinicians make new discoveries and develop new treatments for ALS.